Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection

BACKGROUND: Mass drug administration (MDA) of 20 mg/kg (maximum 1 g in adults) azithromycin for ocular Chlamydia trachomatis (CT) infection is a key component of the WHO trachoma elimination strategy. However, this dose may be suboptimal in Mycoplasma genitalium infection and may encourage emergence...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrison, Mark Andrew, Harding-Esch, Emma Michele, Marks, Michael, Pond, Marcus James, Butcher, Robert, Solomon, Anthony W, Zhou, Liqing, Tan, NgeeKeong, Nori, Achyuta V, Kako, Henry, Sokana, Oliver, Mabey, David C W, Sadiq, Syed Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860407/
https://www.ncbi.nlm.nih.gov/pubmed/30981999
http://dx.doi.org/10.1136/sextrans-2018-053938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860407/
https://www.ncbi.nlm.nih.gov/pubmed/30981999
http://dx.doi.org/10.1136/sextrans-2018-053938

Ejemplares similares